Staphylococcus aureus subsp. aureus Rosenbach (ATCC® BAA-1717)

Strain Designations: TCH1516 [USA300-HOU-MR]  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations TCH1516 [USA300-HOU-MR]
Application
Emerging infectious disease research
Drug discovery
Isolation
From adolescent patient with severe sepsis syndrome; Texas Children's Hospital
Type Strain no
Biosafety Level 2
Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Genome Sequenced Strain

Staphylococcus aureus subsp. aureus USA300_TCH1516, complete genome

Type Strain no
Antibiotic Resistance Methicillin resistant
Comments
Genome sequencing strain
PFGE type: USA300
SCCmec type IVa
Medium Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor K Hulten
Isolation
From adolescent patient with severe sepsis syndrome; Texas Children's Hospital
References

Highlander SK, et al. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol. 7: 99, 2007. PubMed: 17986343

Cross References

Nucleotide (GenBank) : CP000730 Staphylococcus aureus subsp. aureus USA300_TCH1516, complete genome

Nucleotide (GenBank) : CP000731 Staphylococcus aureus subsp. aureus USA300_TCH1516 plasmid pUSA300HOUMR, complete sequence

Nucleotide (GenBank) : CP001544 Staphylococcus aureus subsp. aureus USA300_TCH1516 plasmid pUSA01-HOU, complete sequence

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Other Documentation